MedTrace Logo

Functional and Lymphocytic Markers of Respiratory Morbidity in Hyperoxic Preemies

NCT01607216 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 277

Last updated 2020-01-13

No results posted yet for this study

Summary

This is an observational study that proposes to collect clinical, physiological, cellular and molecular information in an attempt to identify a set of factors that may predict the risk for persistent lung disease in babies born prematurely.

Conditions

  • Prematurity
  • Symptomatic Respiratory Disease
  • Bronchopulmonary Dysplasia

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • University at Buffalo

    collaborator OTHER

  • University of Rochester

    lead OTHER

Principal Investigators

  • Gloria Pryhuber, MD · University of Rochester

  • Rita Ryan, MD · University at Buffalo

  • Thomas Mariani, PhD · University of Rochester

Eligibility

Max Age
7 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2015-07-31
Completion
2015-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01607216 on ClinicalTrials.gov